Ghost Tree Capital, LLC Sarepta Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

A detailed history of Ghost Tree Capital, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 120,000 shares of SRPT stock, worth $1.95 Million. This represents 5.62% of its overall portfolio holdings.

Number of Shares

120,000

Previous 55,000 118.18%

Holding current value

$1.95 Million

Previous $8.69 Million 72.47%

% of portfolio

5.62%

Previous 3.55%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $8.08 Million - $10.2 Million	65,000 Added 118.18%	120,000 $15 Million
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $7.93 Million - $11.5 Million	-70,000 Reduced 56.0%	55,000 $8.69 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $2.34 Million - $3.54 Million	25,000 Added 25.0%	125,000 $16.2 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $4.04 Million - $7.49 Million	60,000 Added 150.0%	100,000 $9.64 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $4.61 Million - $5.56 Million	-45,000 Reduced 52.94%	40,000 $4.85 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $2.66 Million - $3.93 Million	25,000 Added 41.67%	85,000 $9.73 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $587,650 - $779,950	5,000 Added 9.09%	60,000 $8.27 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $5.55 Million - $7.27 Million	-55,000 Reduced 50.0%	55,000 $7.13 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $1.51 Million - $2.38 Million	-20,000 Reduced 15.38%	110,000 $12.2 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $5.02 Million - $7.08 Million	80,000 Added 160.0%	130,000 $9.75 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $3.16 Million - $4.52 Million	-50,000 Reduced 50.0%	50,000 $3.91 Million
Q4 2021 Feb 16, 2022	BUY	$77.28 - $99.42 $7.73 Million - $9.94 Million	100,000 New	100,000 $9.01 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $2.89 Million - $6.76 Million	-40,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $3.14 Million - $4.47 Million	-25,000 Reduced 38.46%	40,000 $6.82 Million
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $8.26 Million - $11.2 Million	65,000 New	65,000 $9.13 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $5.35 Million - $8.56 Million	-65,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $11.9 Million - $21 Million	-155,000 Reduced 70.45%	65,000 $8.39 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $5.1 Million - $11 Million	-70,000 Reduced 24.14%	220,000 $16.6 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $32.5 Million - $44.1 Million	290,000 New	290,000 $44.1 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $7.47 Million - $10.6 Million	-70,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $13.6 Million - $20.8 Million	-140,000 Reduced 66.67%	70,000 $7.64 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $4.04 Million - $5.65 Million	35,000 Added 20.0%	210,000 $33.9 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $4.3 Million - $9.22 Million	-60,000 Reduced 25.53%	175,000 $23.1 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $12.7 Million - $19.3 Million	235,000 New	235,000 $17.4 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $4.76 Million - $5.68 Million	-100,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $3.57 Million - $4.72 Million	100,000	100,000 $4.54 Million

Others Institutions Holding SRPT

# of Institutions

493

Shares Held

90.8M

Call Options Held

1.39M

Put Options Held

1.15M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.42B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Sarepta Therapeutics, Inc. Transaction History